Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

May 14, 2015

Primary Completion Date

August 26, 2016

Study Completion Date

March 27, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Linagliptin

DRUG

Empagliflozin placebo + linagliptin placebo low dose

Matching placebo empagliflozin + linagliptin

DRUG

Empagliflozin + linagliptin low dose

tablet

DRUG

Linagliptin placebo

Matching placebo linagliptin

DRUG

Empagliflozin + linagliptin high dose

tablet

DRUG

Empa + lina highdose placebo

Trial Locations (40)

454-0933

Nagoya Kyoritsu Hospital, Aichi, Nagoya

277-0825

Kashiwa City Hospital, Chiba, Kashiwa

811-1346

Otabe internal medicine clinic, Fukuoka, Fukuoka

819-1104

Nakamura Cardiovascular Clinic, Fukuoka, Itoshima

830-0023

Tanaka I.M. Clinic, Fukuoka, I.M., Fukuoka, Kurume

963-8851

Seino I.M. Clinic, Fukushima, I.M., Fukushima, Koriyama

733-0011

Hiraoka Naika Clinic, Hiroshima, I.M., Hiroshima, Hiroshima

003-0026

Matsuda Cardiovascular Clinic, Hokkaido, Sapporo

006-0811

Teine Keijinkai Clinic, Hokkaido, Sapporo

006-0852

Mita Internal Medicine Cardiology Clinic, Hokkaido, Sapporo

063-0826

Miyanosawa Clinic of Internal Medicine and Cardiology, Hokkaido, Sapporo

306-0232

Itabashi Diabetic medicine and Dermatology Clinic, Ibaraki, Koga

311-0113

Nakakinen Clinic, Ibaraki, Naka

214-0014

Kubota Clinic, Kanagawa, Kawasaki

252-0375

Kitasato University Hospital, Kanagawa, Sagamihara

235-0045

H.E.C Science Clinic, Kanagawa, Yokohama

604-8151

Yoshimasa Diabetes & Endocrine Clinic, Kyoto, Kyoto

607-8062

Rakuwakai Otowa Hospital, Kyoto, Kyoto

615-8125

Medical Corporation Hayashi Katagihara Clinic, Kyoto, Kyoto

390-0848

Miyamoto Naika Clinic, Nagano, I.M., Nagano, Matsumoto

399-0036

Gibo Hepatology Clinic, Nagano, Digestive Tract I.M., Nagano, Matsumoto

577-0803

Takekawa Clinic, Osaka, I.M., Osaka, Higashi-Osaka

532-0003

Medical Corporation Koseikai Fukuda Naika Clinic, Osaka, Osaka

532-0026

Kinugawa Cardiovascular Internal Medicine clinic, Osaka, Osaka

536-0023

Sato Hospital, Osaka, Osaka

555-0032

Nakaoka Clinic, Osaka, Osaka

565-0853

OCROM Clinic, Osaka, Suita

569-1123

Miyauchi Medical Center, Osaka, Takatsuki

357-0024

Medical Corporation Shinseikai Mashiba Clinic, Saitama, Hanno

350-0851

Asano Clinic, Saitama, Kawagoe

336-0963

Medical Corporation Fusa Shimizu Clinic Fusa, Saitama, Saitama

359-1161

Ogino Clinic, Saitama, Tokorozawa

101-0047

Kanda Clinic, Tokyo, Chiyoda-ku

103-0027

Fukuwa Clinic, Tokyo, Chuo-ku

Tokyo-Eki Center-building Clinic, Tokyo, Chuo-ku

192-0046

Myojin Tou Clinic, Tokyo, Hachioji

136-0073

Sawai Medical Clinic, Tokyo, Koto-ku

153-0051

Mishuku Hospital, Tokyo, Meguro-ku

140-8522

Toshiba General Hospital, Tokyo, Shinagawa-ku

160-0022

ToCROM Clinic, Tokyo, Shinjuku-ku

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY